Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
170 |
|
| Actual shortage: | 6 (4%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 5 (3%) | |
| Resolved: | 158 (93%) | |
Discontinuation Reports |
54 |
|
| To be discontinued: | 2 (4%) | |
| Discontinued: | 52 (96%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (15%) |
|
Overdue reports |
5 (56%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-04-29 | 2019-08-12 | 82741 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-13 | 79071 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-03-27 | 79064 |
| LOPRESOR SR 100MG | 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-11-30 | 2018-06-28 | 31273 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-25 | 2020-02-04 | 94696 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79076 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79079 |
| LUTATHERA | 370MBq | SOLUTION | Resolved | 2022-05-06 | 2022-06-14 | 160113 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| MAXIDEX | 0.1% | OINTMENT | Anticipated shortage | 2025-04-28 | 2025-04-28 | 255940 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-01-09 | 2018-01-19 | 35401 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2017-07-27 | 2017-09-08 | 17417 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | OINTMENT | Actual shortage | 2025-04-28 | 2025-04-29 | 255932 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 1MG 6000UNIT 3.5MG | SUSPENSION | Resolved | 2018-11-23 | 2019-02-05 | 67487 |
| MAXITROL | 1MG 6000UNIT 3.5MG | OINTMENT | Resolved | 2018-03-26 | 2018-04-25 | 44012 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEGRETOL CHEWTABS 200 MG | 200MG | TABLET | Discontinued | 2017-05-01 | 2017-06-06 | 8500 |
| TRANSDERM-NITRO 0.2 | 0.2MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119960 |
| TRANSDERM-NITRO 0.4 | 0.4MG | PATCH (EXTENDED RELEASE) | Discontinued | 2020-07-10 | 2020-12-21 | 119964 |
| TRANSDERM-NITRO 0.6 | 0.6MG | PATCH (EXTENDED RELEASE) | Discontinued | 2021-05-05 | 2022-01-17 | 138767 |
| VOLTAREN | 50MG | TABLET (DELAYED-RELEASE) | Discontinued | 2020-01-08 | 2020-03-10 | 102699 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Discontinued | 2019-09-11 | 2019-11-07 | 93561 |
| VOLTAREN SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-07-10 | 2019-09-06 | 89039 |
| VOLTAREN SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-04-02 | 2019-09-11 | 80298 |
| VOLTAREN | 100MG | SUPPOSITORY | Discontinued | 2017-05-01 | 2017-11-02 | 8504 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-09-23 | 123900 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| ZOFRAN | 2MG | SOLUTION | Discontinued | 2020-09-09 | 2021-05-05 | 123894 |